{"transactions":[{"id":2091579,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - GENERAL COUNSEL"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-12-09T21:48:08.000Z","date":"2022-12-08","kind":"exercise","acquired":false,"shares":7450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully exercisable."}],"balance_after":29762,"derivative":{"exercise_price":31.2625,"expiration_date":"2024-08-09","underlying":"Common Stock","underlying_shares":7450},"source":{"system":"sec-edgar","filing":"0001415889-22-012330","document":"form4-12092022_091248.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/842023/000141588922012330/form4-12092022_091248.xml","form_type":"4"}},{"id":2091578,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - GENERAL COUNSEL"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-12-09T21:48:08.000Z","date":"2022-12-07","kind":"exercise","acquired":false,"shares":800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully exercisable."}],"balance_after":37212,"derivative":{"exercise_price":31.2625,"expiration_date":"2024-08-09","underlying":"Common Stock","underlying_shares":800},"source":{"system":"sec-edgar","filing":"0001415889-22-012330","document":"form4-12092022_091248.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/842023/000141588922012330/form4-12092022_091248.xml","form_type":"4"}},{"id":2091577,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2022-12-09T21:48:08.000Z","date":"2022-12-08","kind":"sale","acquired":false,"shares":7450,"price":82.1222,"value":611810.39,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from 82.0000 to 82.4900, inclusive.  The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":26092,"source":{"system":"sec-edgar","filing":"0001415889-22-012330","document":"form4-12092022_091248.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/842023/000141588922012330/form4-12092022_091248.xml","form_type":"4"}},{"id":2091576,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2022-12-09T21:48:08.000Z","date":"2022-12-08","kind":"exercise","acquired":true,"shares":7450,"price":31.2625,"value":232905.625,"ownership":{"direct":true},"balance_after":33542,"source":{"system":"sec-edgar","filing":"0001415889-22-012330","document":"form4-12092022_091248.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/842023/000141588922012330/form4-12092022_091248.xml","form_type":"4"}},{"id":2091575,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2022-12-09T21:48:08.000Z","date":"2022-12-07","kind":"sale","acquired":false,"shares":800,"price":82.0063,"value":65605.04,"ownership":{"direct":true},"balance_after":26092,"source":{"system":"sec-edgar","filing":"0001415889-22-012330","document":"form4-12092022_091248.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000141588922012330/form4-12092022_091248.xml","form_type":"4"}},{"id":2091574,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - GENERAL COUNSEL"}}],"security":"Common Stock","published_at":"2022-12-09T21:48:08.000Z","date":"2022-12-07","kind":"exercise","acquired":true,"shares":800,"price":31.2625,"value":25010.0,"ownership":{"direct":true},"balance_after":26892,"source":{"system":"sec-edgar","filing":"0001415889-22-012330","document":"form4-12092022_091248.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000141588922012330/form4-12092022_091248.xml","form_type":"4"}},{"id":2182889,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"officer":true,"officer_title":"SVP - General Counsel"}}],"security":"Restricted Stock Units","published_at":"2022-08-17T21:22:17.000Z","date":"2022-08-15","kind":"grant","acquired":true,"shares":1984,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"661 shares vest on each of 8/15/2023 and 8/15/2025, and 662 shares vest on 8/15/2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"661 shares vest on each of 8/15/2023 and 8/15/2025, and 662 shares vest on 8/15/2024."}],"balance_after":1984,"derivative":{"underlying":"Common Stock","underlying_shares":1984},"source":{"system":"sec-edgar","filing":"0001437749-22-020845","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/842023/000143774922020845/rdgdoc.xml","form_type":"4"}},{"id":2182888,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"officer":true,"officer_title":"SVP - General Counsel"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-08-17T21:22:17.000Z","date":"2022-08-15","kind":"grant","acquired":true,"shares":6166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to purchase 1,542 shares vest on each of 8/15/2023 and 8/15/2025 and options to purchase 1,541 shares vest on 8/15/2024 and 8/15/2026."}],"balance_after":6166,"derivative":{"exercise_price":378.08,"expiration_date":"2029-08-15","underlying":"Common Stock","underlying_shares":6166},"source":{"system":"sec-edgar","filing":"0001437749-22-020845","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/842023/000143774922020845/rdgdoc.xml","form_type":"4"}},{"id":2190121,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"officer":true,"officer_title":"SVP - General Counsel"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-08-10T22:08:51.000Z","date":"2022-08-08","kind":"exercise","acquired":false,"shares":563,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully exercisable."}],"balance_after":16562,"derivative":{"exercise_price":177.32,"expiration_date":"2025-08-08","underlying":"Common Stock","underlying_shares":563},"source":{"system":"sec-edgar","filing":"0001437749-22-019862","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/842023/000143774922019862/rdgdoc.xml","form_type":"4"}},{"id":2190120,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"officer":true,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2022-08-10T22:08:51.000Z","date":"2022-08-08","kind":"exercise","acquired":true,"shares":563,"price":177.32,"value":99831.16,"ownership":{"direct":true},"balance_after":6523,"source":{"system":"sec-edgar","filing":"0001437749-22-019862","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000143774922019862/rdgdoc.xml","form_type":"4"}},{"id":2191435,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"officer":true,"officer_title":"SVP - General Counsel"}}],"security":"Restricted Stock Units","published_at":"2022-08-09T22:59:36.000Z","date":"2022-08-07","kind":"exercise","acquired":false,"shares":1969,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On 8/7/22, the Board of Directors certified vesting of 1,969 performance RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On 8/7/22, the Board of Directors certified vesting of 1,969 performance RSUs."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1969},"source":{"system":"sec-edgar","filing":"0001437749-22-019665","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/842023/000143774922019665/rdgdoc.xml","form_type":"4"}},{"id":2191434,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"officer":true,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2022-08-09T22:59:36.000Z","date":"2022-08-07","kind":"tax_withholding","acquired":false,"shares":969,"price":382.97,"value":371097.93,"ownership":{"direct":true},"balance_after":5960,"source":{"system":"sec-edgar","filing":"0001437749-22-019665","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/842023/000143774922019665/rdgdoc.xml","form_type":"4"}},{"id":2191433,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"officer":true,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2022-08-09T22:59:36.000Z","date":"2022-08-07","kind":"exercise","acquired":true,"shares":1969,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6929,"source":{"system":"sec-edgar","filing":"0001437749-22-019665","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/842023/000143774922019665/rdgdoc.xml","form_type":"4"}},{"id":2191432,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"officer":true,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2022-08-09T22:59:36.000Z","date":"2021-10-26","kind":"gift","acquired":true,"shares":1330,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust #2"},"balance_after":1330,"source":{"system":"sec-edgar","filing":"0001437749-22-019665","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/842023/000143774922019665/rdgdoc.xml","form_type":"4"}},{"id":2191431,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"officer":true,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2022-08-09T22:59:36.000Z","date":"2021-10-26","kind":"gift","acquired":false,"shares":1330,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4960,"source":{"system":"sec-edgar","filing":"0001437749-22-019665","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/842023/000143774922019665/rdgdoc.xml","form_type":"4"}},{"id":2191430,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"officer":true,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2022-08-09T22:59:36.000Z","date":"2021-10-26","kind":"gift","acquired":true,"shares":1330,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust #1"},"balance_after":1330,"source":{"system":"sec-edgar","filing":"0001437749-22-019665","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000143774922019665/rdgdoc.xml","form_type":"4"}},{"id":2191429,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"officer":true,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2022-08-09T22:59:36.000Z","date":"2021-10-26","kind":"gift","acquired":false,"shares":1330,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6290,"source":{"system":"sec-edgar","filing":"0001437749-22-019665","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000143774922019665/rdgdoc.xml","form_type":"4"}},{"id":2577941,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-09-07T20:58:19.000Z","date":"2021-09-02","kind":"exercise","acquired":false,"shares":6871,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully exercisable."}],"balance_after":9503,"derivative":{"exercise_price":125.05,"expiration_date":"2024-08-09","underlying":"Common Stock","underlying_shares":6871},"source":{"system":"sec-edgar","filing":"0000914190-21-000358","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000358/edgar.xml","form_type":"4"}},{"id":2577940,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2021-09-07T20:58:19.000Z","date":"2021-09-02","kind":"sale","acquired":false,"shares":1576,"price":510.8208,"value":805053.5808,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $510.245 to $511.16, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":7620,"source":{"system":"sec-edgar","filing":"0000914190-21-000358","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000358/edgar.xml","form_type":"4"}},{"id":2577939,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2021-09-07T20:58:19.000Z","date":"2021-09-02","kind":"sale","acquired":false,"shares":5295,"price":509.6715,"value":2698710.5925,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $509.23 to $510.07, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":9196,"source":{"system":"sec-edgar","filing":"0000914190-21-000358","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000358/edgar.xml","form_type":"4"}},{"id":2577938,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2021-09-07T20:58:19.000Z","date":"2021-09-02","kind":"exercise","acquired":true,"shares":6871,"price":125.05,"value":859218.55,"ownership":{"direct":true},"balance_after":14491,"source":{"system":"sec-edgar","filing":"0000914190-21-000358","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000358/edgar.xml","form_type":"4"}},{"id":2582673,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-09-02T20:48:36.000Z","date":"2021-08-31","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully exercisable."}],"balance_after":16374,"derivative":{"exercise_price":125.05,"expiration_date":"2024-08-09","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000914190-21-000321","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000321/edgar.xml","form_type":"4"}},{"id":2582672,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2021-09-02T20:48:36.000Z","date":"2021-08-31","kind":"sale","acquired":false,"shares":3108,"price":506.1167,"value":1573010.7036,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $505.92 to $506.40, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":7620,"source":{"system":"sec-edgar","filing":"0000914190-21-000321","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000321/edgar.xml","form_type":"4"}},{"id":2582671,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2021-09-02T20:48:36.000Z","date":"2021-08-31","kind":"sale","acquired":false,"shares":1569,"price":505.2612,"value":792754.8228,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $504.63 to $505.57, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":10728,"source":{"system":"sec-edgar","filing":"0000914190-21-000321","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000321/edgar.xml","form_type":"4"}},{"id":2582670,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2021-09-02T20:48:36.000Z","date":"2021-08-31","kind":"sale","acquired":false,"shares":323,"price":503.2383,"value":162545.9709,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $503.06 to $503.43, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":12297,"source":{"system":"sec-edgar","filing":"0000914190-21-000321","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000321/edgar.xml","form_type":"4"}},{"id":2582669,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2021-09-02T20:48:36.000Z","date":"2021-08-31","kind":"exercise","acquired":true,"shares":5000,"price":125.05,"value":625250.0,"ownership":{"direct":true},"balance_after":12620,"source":{"system":"sec-edgar","filing":"0000914190-21-000321","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000321/edgar.xml","form_type":"4"}},{"id":2594115,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-08-23T20:15:56.000Z","date":"2021-08-19","kind":"exercise","acquired":false,"shares":799,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully exercisable."}],"balance_after":8704,"derivative":{"exercise_price":125.05,"expiration_date":"2024-08-09","underlying":"Common Stock","underlying_shares":799},"source":{"system":"sec-edgar","filing":"0000914190-21-000288","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000288/edgar.xml","form_type":"4"}},{"id":2594114,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-08-23T20:15:56.000Z","date":"2021-08-19","kind":"exercise","acquired":false,"shares":3538,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":106.59,"expiration_date":"2023-08-18","underlying":"Common Stock","underlying_shares":3538},"source":{"system":"sec-edgar","filing":"0000914190-21-000288","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000288/edgar.xml","form_type":"4"}},{"id":2594113,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2021-08-23T20:15:56.000Z","date":"2021-08-19","kind":"sale","acquired":false,"shares":600,"price":475.0536,"value":285032.16,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $474.79 to 475.5250, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":7620,"source":{"system":"sec-edgar","filing":"0000914190-21-000288","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000288/edgar.xml","form_type":"4"}},{"id":2594112,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2021-08-23T20:15:56.000Z","date":"2021-08-19","kind":"sale","acquired":false,"shares":1838,"price":474.1168,"value":871426.6784,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $473.6350 to $474.57, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":8220,"source":{"system":"sec-edgar","filing":"0000914190-21-000288","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000288/edgar.xml","form_type":"4"}},{"id":2594111,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2021-08-23T20:15:56.000Z","date":"2021-08-19","kind":"sale","acquired":false,"shares":1100,"price":473.0823,"value":520390.53,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $472.50 to $473.46, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":10058,"source":{"system":"sec-edgar","filing":"0000914190-21-000288","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000288/edgar.xml","form_type":"4"}},{"id":2594110,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2021-08-23T20:15:56.000Z","date":"2021-08-19","kind":"exercise","acquired":true,"shares":799,"price":125.05,"value":99914.95,"ownership":{"direct":true},"balance_after":11158,"source":{"system":"sec-edgar","filing":"0000914190-21-000288","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000288/edgar.xml","form_type":"4"}},{"id":2594109,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2021-08-23T20:15:56.000Z","date":"2021-08-19","kind":"exercise","acquired":true,"shares":3538,"price":106.59,"value":377115.42,"ownership":{"direct":true},"balance_after":10359,"source":{"system":"sec-edgar","filing":"0000914190-21-000288","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000288/edgar.xml","form_type":"4"}},{"id":2609279,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-08-10T22:20:44.000Z","date":"2021-08-06","kind":"grant","acquired":true,"shares":6080,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"Options to purchase 1,520 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025."}],"balance_after":6080,"derivative":{"exercise_price":481.82,"expiration_date":"2028-08-06","underlying":"Common Stock","underlying_shares":6080},"source":{"system":"sec-edgar","filing":"0000914190-21-000214","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000214/edgar.xml","form_type":"4"}},{"id":2609278,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-08-10T22:20:44.000Z","date":"2021-08-06","kind":"grant","acquired":true,"shares":4560,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)."}],"balance_after":4560,"derivative":{"exercise_price":481.82,"expiration_date":"2028-08-06","underlying":"Common Stock","underlying_shares":4560},"source":{"system":"sec-edgar","filing":"0000914190-21-000214","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000214/edgar.xml","form_type":"4"}},{"id":2609277,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Restricted Stock Units","published_at":"2021-08-10T22:20:44.000Z","date":"2021-08-06","kind":"grant","acquired":true,"shares":1167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F11","text":"Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)."}],"balance_after":1167,"derivative":{"underlying":"Common Stock","underlying_shares":1167},"source":{"system":"sec-edgar","filing":"0000914190-21-000214","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000214/edgar.xml","form_type":"4"}},{"id":2609276,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Restricted Stock Units","published_at":"2021-08-10T22:20:44.000Z","date":"2021-08-08","kind":"exercise","acquired":false,"shares":1374,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vested in full on 8/8/2021 upon the certification of achievement of performance goals."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Vested in full on 8/8/2021 upon the certification of achievement of performance goals."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1374},"source":{"system":"sec-edgar","filing":"0000914190-21-000214","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000214/edgar.xml","form_type":"4"}},{"id":2609275,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2021-08-10T22:20:44.000Z","date":"2021-08-08","kind":"tax_withholding","acquired":false,"shares":677,"price":481.82,"value":326192.14,"ownership":{"direct":true},"balance_after":6821,"source":{"system":"sec-edgar","filing":"0000914190-21-000214","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000214/edgar.xml","form_type":"4"}},{"id":2609274,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2021-08-10T22:20:44.000Z","date":"2021-08-08","kind":"exercise","acquired":true,"shares":1374,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7498,"source":{"system":"sec-edgar","filing":"0000914190-21-000214","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000214/edgar.xml","form_type":"4"}},{"id":2816698,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-03-03T21:28:15.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":10997,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10997,"derivative":{"exercise_price":372.44,"exercise_date":"2022-08-31","expiration_date":"2028-03-01","underlying":"Common Stock","underlying_shares":10997},"source":{"system":"sec-edgar","filing":"0000914190-21-000072","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000072/edgar.xml","form_type":"4"}},{"id":2856553,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-02-17T21:42:04.000Z","date":"2021-02-12","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully exercisable."}],"balance_after":3538,"derivative":{"exercise_price":106.59,"expiration_date":"2023-08-18","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000914190-21-000048","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000048/edgar.xml","form_type":"4"}},{"id":2856552,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2021-02-17T21:42:04.000Z","date":"2021-02-12","kind":"sale","acquired":false,"shares":3326,"price":399.1165,"value":1327461.479,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $399.00 to $399.465, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":6124,"source":{"system":"sec-edgar","filing":"0000914190-21-000048","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000048/edgar.xml","form_type":"4"}},{"id":2856551,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2021-02-17T21:42:04.000Z","date":"2021-02-12","kind":"sale","acquired":false,"shares":6674,"price":398.3954,"value":2658890.8996,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $398.00 to $398.995, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":9450,"source":{"system":"sec-edgar","filing":"0000914190-21-000048","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000048/edgar.xml","form_type":"4"}},{"id":2856550,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2021-02-17T21:42:04.000Z","date":"2021-02-12","kind":"exercise","acquired":true,"shares":10000,"price":106.59,"value":1065900.0,"ownership":{"direct":true},"balance_after":16124,"source":{"system":"sec-edgar","filing":"0000914190-21-000048","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000048/edgar.xml","form_type":"4"}},{"id":2961862,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-02T23:01:48.000Z","date":"2020-11-30","kind":"exercise","acquired":false,"shares":10857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":106.59,"expiration_date":"2023-08-18","underlying":"Common Stock","underlying_shares":10857},"source":{"system":"sec-edgar","filing":"0001562180-20-007023","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218020007023/primarydocument.xml","form_type":"4"}},{"id":2961861,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-02T23:01:48.000Z","date":"2020-11-30","kind":"exercise","acquired":false,"shares":938,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully exercisable."}],"balance_after":13538,"derivative":{"exercise_price":106.59,"expiration_date":"2023-08-18","underlying":"Common Stock","underlying_shares":938},"source":{"system":"sec-edgar","filing":"0001562180-20-007023","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218020007023/primarydocument.xml","form_type":"4"}},{"id":2961860,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2020-12-02T23:01:48.000Z","date":"2020-11-30","kind":"sale","acquired":false,"shares":707,"price":302.8185,"value":214092.6795,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $302.70  to $302.89, inclusive.  The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":6124,"source":{"system":"sec-edgar","filing":"0001562180-20-007023","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218020007023/primarydocument.xml","form_type":"4"}},{"id":2961859,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2020-12-02T23:01:48.000Z","date":"2020-11-30","kind":"sale","acquired":false,"shares":6783,"price":302.1489,"value":2049475.9887,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from  $301.65 to $302.63, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":6831,"source":{"system":"sec-edgar","filing":"0001562180-20-007023","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218020007023/primarydocument.xml","form_type":"4"}},{"id":2961858,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2020-12-02T23:01:48.000Z","date":"2020-11-30","kind":"sale","acquired":false,"shares":3367,"price":301.3239,"value":1014557.5713,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $300.65 to 301.64, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":13614,"source":{"system":"sec-edgar","filing":"0001562180-20-007023","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218020007023/primarydocument.xml","form_type":"4"}},{"id":2961857,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2020-12-02T23:01:48.000Z","date":"2020-11-30","kind":"exercise","acquired":true,"shares":938,"price":106.59,"value":99981.42,"ownership":{"direct":true},"balance_after":16981,"source":{"system":"sec-edgar","filing":"0001562180-20-007023","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218020007023/primarydocument.xml","form_type":"4"}},{"id":2961856,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2020-12-02T23:01:48.000Z","date":"2020-11-30","kind":"exercise","acquired":true,"shares":10857,"price":106.59,"value":1157247.63,"ownership":{"direct":true},"balance_after":16043,"source":{"system":"sec-edgar","filing":"0001562180-20-007023","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218020007023/primarydocument.xml","form_type":"4"}},{"id":3062536,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Restricted Stock Units","published_at":"2020-08-11T22:22:19.000Z","date":"2020-08-09","kind":"exercise","acquired":false,"shares":1724,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On 8/9/2020, the Board of Directors certified vesting of 1,724 performance RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On 8/9/2020, the Board of Directors certified vesting of 1,724 performance RSUs."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1724},"source":{"system":"sec-edgar","filing":"0000914190-20-000292","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419020000292/edgar.xml","form_type":"4"}},{"id":3062535,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2020-08-11T22:22:19.000Z","date":"2020-08-09","kind":"tax_withholding","acquired":false,"shares":849,"price":265.76,"value":225630.24,"ownership":{"direct":true},"balance_after":5186,"source":{"system":"sec-edgar","filing":"0000914190-20-000292","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419020000292/edgar.xml","form_type":"4"}},{"id":3062534,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2020-08-11T22:22:19.000Z","date":"2020-08-09","kind":"exercise","acquired":true,"shares":1724,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6035,"source":{"system":"sec-edgar","filing":"0000914190-20-000292","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419020000292/edgar.xml","form_type":"4"}},{"id":3065275,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-08-07T22:40:46.000Z","date":"2020-08-05","kind":"grant","acquired":true,"shares":8325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"Options to purchase 2,775 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023."}],"balance_after":8325,"derivative":{"exercise_price":267.87,"expiration_date":"2027-08-05","underlying":"Common Stock","underlying_shares":8325},"source":{"system":"sec-edgar","filing":"0000914190-20-000247","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419020000247/edgar.xml","form_type":"4"}},{"id":3065274,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-08-07T22:40:46.000Z","date":"2020-08-05","kind":"grant","acquired":true,"shares":8325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021"}],"balance_after":8325,"derivative":{"exercise_price":267.87,"expiration_date":"2027-08-05","underlying":"Common Stock","underlying_shares":8325},"source":{"system":"sec-edgar","filing":"0000914190-20-000247","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419020000247/edgar.xml","form_type":"4"}},{"id":3065273,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-08-07T22:40:46.000Z","date":"2020-08-05","kind":"grant","acquired":true,"shares":9990,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Options to purchase 2,498 shares vest on each of 8/5/2021 and 8/5/2022 and options to purchase 2,497 shares vest on each of 8/5/2023 and 8/5/2024."}],"balance_after":9990,"derivative":{"exercise_price":267.87,"expiration_date":"2027-08-05","underlying":"Common Stock","underlying_shares":9990},"source":{"system":"sec-edgar","filing":"0000914190-20-000247","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419020000247/edgar.xml","form_type":"4"}},{"id":3065272,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-08-07T22:40:46.000Z","date":"2020-08-05","kind":"grant","acquired":true,"shares":7492,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)."}],"balance_after":7492,"derivative":{"exercise_price":267.87,"expiration_date":"2027-08-05","underlying":"Common Stock","underlying_shares":7492},"source":{"system":"sec-edgar","filing":"0000914190-20-000247","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419020000247/edgar.xml","form_type":"4"}},{"id":3065271,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Restricted Stock Units","published_at":"2020-08-07T22:40:46.000Z","date":"2020-08-05","kind":"grant","acquired":true,"shares":1679,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)."}],"balance_after":1679,"derivative":{"underlying":"Common Stock","underlying_shares":1679},"source":{"system":"sec-edgar","filing":"0000914190-20-000247","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419020000247/edgar.xml","form_type":"4"}},{"id":3084616,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-13T20:02:56.000Z","date":"2020-07-09","kind":"exercise","acquired":false,"shares":9079,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Vests 2,500 share(s) on 07-Aug-2016, 2,500 share(s) on 07-Aug-2017, 2,500 share(s) on 07-Aug-2018, 1,579 share(s) on 07-Aug-2019"}],"balance_after":921,"derivative":{"exercise_price":108.49,"expiration_date":"2022-08-07","underlying":"Common Stock","underlying_shares":9079},"source":{"system":"sec-edgar","filing":"0001562180-20-005109","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218020005109/primarydocument.xml","form_type":"4"}},{"id":3084615,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2020-07-13T20:02:56.000Z","date":"2020-07-09","kind":"sale","acquired":false,"shares":74,"price":278.84,"value":20634.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2020."}],"balance_after":4311,"source":{"system":"sec-edgar","filing":"0001562180-20-005109","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218020005109/primarydocument.xml","form_type":"4"}},{"id":3084614,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2020-07-13T20:02:56.000Z","date":"2020-07-09","kind":"sale","acquired":false,"shares":2746,"price":278.061,"value":763555.506,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $277.7700 to $278.6600, inclusive.  The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":4385,"source":{"system":"sec-edgar","filing":"0001562180-20-005109","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218020005109/primarydocument.xml","form_type":"4"}},{"id":3084613,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2020-07-13T20:02:56.000Z","date":"2020-07-09","kind":"sale","acquired":false,"shares":1954,"price":277.2836,"value":541812.1544,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $276.6500 to $277.6200, inclusive.  The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":7131,"source":{"system":"sec-edgar","filing":"0001562180-20-005109","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218020005109/primarydocument.xml","form_type":"4"}},{"id":3084612,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2020-07-13T20:02:56.000Z","date":"2020-07-09","kind":"sale","acquired":false,"shares":400,"price":276.025,"value":110410.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $275.4000 to $276.3500, inclusive.  The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":9085,"source":{"system":"sec-edgar","filing":"0001562180-20-005109","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218020005109/primarydocument.xml","form_type":"4"}},{"id":3084611,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2020-07-13T20:02:56.000Z","date":"2020-07-09","kind":"sale","acquired":false,"shares":918,"price":274.8048,"value":252270.8064,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $274.3100 to $275.2100, inclusive.  The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":9485,"source":{"system":"sec-edgar","filing":"0001562180-20-005109","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218020005109/primarydocument.xml","form_type":"4"}},{"id":3084610,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2020-07-13T20:02:56.000Z","date":"2020-07-09","kind":"sale","acquired":false,"shares":2042,"price":273.3317,"value":558143.3314,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $272.8500 to $273.7900, inclusive.  The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":10403,"source":{"system":"sec-edgar","filing":"0001562180-20-005109","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218020005109/primarydocument.xml","form_type":"4"}},{"id":3084609,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2020-07-13T20:02:56.000Z","date":"2020-07-09","kind":"sale","acquired":false,"shares":505,"price":272.4778,"value":137601.289,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $271.8500 to $272.8300, inclusive.  The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":12445,"source":{"system":"sec-edgar","filing":"0001562180-20-005109","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218020005109/primarydocument.xml","form_type":"4"}},{"id":3084608,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2020-07-13T20:02:56.000Z","date":"2020-07-09","kind":"sale","acquired":false,"shares":440,"price":270.9659,"value":119224.996,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $270.6400 to $271.5000, inclusive.  The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":12950,"source":{"system":"sec-edgar","filing":"0001562180-20-005109","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218020005109/primarydocument.xml","form_type":"4"}},{"id":3084607,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2020-07-13T20:02:56.000Z","date":"2020-07-09","kind":"exercise","acquired":true,"shares":9079,"price":108.49,"value":984980.71,"ownership":{"direct":true},"balance_after":13390,"source":{"system":"sec-edgar","filing":"0001562180-20-005109","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218020005109/primarydocument.xml","form_type":"4"}},{"id":3129787,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-06-01T21:58:49.000Z","date":"2020-05-28","kind":"exercise","acquired":false,"shares":5995,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully exercisable."}],"balance_after":10000,"derivative":{"exercise_price":108.49,"expiration_date":"2022-08-07","underlying":"Common Stock","underlying_shares":5995},"source":{"system":"sec-edgar","filing":"0000914190-20-000196","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419020000196/edgar.xml","form_type":"4"}},{"id":3129786,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-06-01T21:58:49.000Z","date":"2020-05-28","kind":"exercise","acquired":false,"shares":1600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":94.35,"expiration_date":"2021-08-12","underlying":"Common Stock","underlying_shares":1600},"source":{"system":"sec-edgar","filing":"0000914190-20-000196","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419020000196/edgar.xml","form_type":"4"}},{"id":3129785,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2020-06-01T21:58:49.000Z","date":"2020-05-28","kind":"sale","acquired":false,"shares":3800,"price":260.3825,"value":989453.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $260.0800 to $261.0400, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":4311,"source":{"system":"sec-edgar","filing":"0000914190-20-000196","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419020000196/edgar.xml","form_type":"4"}},{"id":3129784,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2020-06-01T21:58:49.000Z","date":"2020-05-28","kind":"sale","acquired":false,"shares":2195,"price":259.7172,"value":570079.254,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $259.0500 to $260.0400, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":8111,"source":{"system":"sec-edgar","filing":"0000914190-20-000196","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419020000196/edgar.xml","form_type":"4"}},{"id":3129783,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2020-06-01T21:58:49.000Z","date":"2020-05-28","kind":"exercise","acquired":true,"shares":1600,"price":94.35,"value":150960.0,"ownership":{"direct":true},"balance_after":10306,"source":{"system":"sec-edgar","filing":"0000914190-20-000196","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419020000196/edgar.xml","form_type":"4"}},{"id":3129782,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2020-06-01T21:58:49.000Z","date":"2020-05-28","kind":"exercise","acquired":true,"shares":5995,"price":108.49,"value":650397.55,"ownership":{"direct":true},"balance_after":8706,"source":{"system":"sec-edgar","filing":"0000914190-20-000196","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419020000196/edgar.xml","form_type":"4"}},{"id":3339915,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Stock Options (Right to Buy)","published_at":"2019-12-17T21:32:44.000Z","date":"2019-12-12","kind":"exercise","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Fully exercisable."}],"balance_after":1600,"derivative":{"exercise_price":94.35,"expiration_date":"2021-08-12","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0000914190-19-000488","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419019000488/edgar.xml","form_type":"4"}},{"id":3339914,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2019-12-17T21:32:44.000Z","date":"2019-12-12","kind":"sale","acquired":false,"shares":200,"price":216.75,"value":43350.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $216.71 to $216.79 inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":2711,"source":{"system":"sec-edgar","filing":"0000914190-19-000488","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419019000488/edgar.xml","form_type":"4"}},{"id":3339913,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2019-12-17T21:32:44.000Z","date":"2019-12-12","kind":"sale","acquired":false,"shares":4147,"price":216.0077,"value":895783.9319,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $215.69 to $216.53 inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":2911,"source":{"system":"sec-edgar","filing":"0000914190-19-000488","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419019000488/edgar.xml","form_type":"4"}},{"id":3339912,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2019-12-17T21:32:44.000Z","date":"2019-12-12","kind":"sale","acquired":false,"shares":3227,"price":215.1651,"value":694337.7777,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $214.69 to $215.68 inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":7058,"source":{"system":"sec-edgar","filing":"0000914190-19-000488","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419019000488/edgar.xml","form_type":"4"}},{"id":3339911,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2019-12-17T21:32:44.000Z","date":"2019-12-12","kind":"sale","acquired":false,"shares":426,"price":214.3196,"value":91300.1496,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $213.67 to $214.66 inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":10285,"source":{"system":"sec-edgar","filing":"0000914190-19-000488","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419019000488/edgar.xml","form_type":"4"}},{"id":3339910,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2019-12-17T21:32:44.000Z","date":"2019-12-12","kind":"exercise","acquired":true,"shares":8000,"price":94.35,"value":754800.0,"ownership":{"direct":true},"balance_after":10711,"source":{"system":"sec-edgar","filing":"0000914190-19-000488","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419019000488/edgar.xml","form_type":"4"}},{"id":3339909,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2019-12-17T21:32:44.000Z","date":"2019-11-12","kind":"gift","acquired":false,"shares":492,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a transfer of shares to a charitable donor advised fund. The reporting person retained no pecuniary interest in the transferred shares."}],"balance_after":2711,"source":{"system":"sec-edgar","filing":"0000914190-19-000488","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419019000488/edgar.xml","form_type":"4"}},{"id":3432521,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Restricted Stock Units","published_at":"2019-08-21T20:32:48.000Z","date":"2019-08-19","kind":"exercise","acquired":false,"shares":1759,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On 8/19/2019, the Board of Directors certified vesting of 1,759 performance RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On 8/19/2019, the Board of Directors certified vesting of 1,759 performance RSUs."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1759},"source":{"system":"sec-edgar","filing":"0000914190-19-000328","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419019000328/edgar.xml","form_type":"4"}},{"id":3432520,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2019-08-21T20:32:48.000Z","date":"2019-08-19","kind":"tax_withholding","acquired":false,"shares":745,"price":197.57,"value":147189.65,"ownership":{"direct":true},"balance_after":3203,"source":{"system":"sec-edgar","filing":"0000914190-19-000328","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419019000328/edgar.xml","form_type":"4"}},{"id":3432519,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2019-08-21T20:32:48.000Z","date":"2019-08-19","kind":"exercise","acquired":true,"shares":1759,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock."}],"balance_after":3948,"source":{"system":"sec-edgar","filing":"0000914190-19-000328","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419019000328/edgar.xml","form_type":"4"}},{"id":3442840,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Stock Options (Right to Buy)","published_at":"2019-08-09T20:11:23.000Z","date":"2019-08-07","kind":"grant","acquired":true,"shares":13290,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Options to purchase 3,323 shares vest on each of 8/7/2020 and 8/7/2021 and options to purchase 3,322 shares vest on each of 8/7/2022 and 8/7/2023."}],"balance_after":13290,"derivative":{"exercise_price":190.41,"expiration_date":"2026-08-07","underlying":"Common Stock","underlying_shares":13290},"source":{"system":"sec-edgar","filing":"0000914190-19-000259","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419019000259/edgar.xml","form_type":"4"}},{"id":3442839,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Stock Options (Right to Buy)","published_at":"2019-08-09T20:11:23.000Z","date":"2019-08-07","kind":"grant","acquired":true,"shares":9968,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)."}],"balance_after":9968,"derivative":{"exercise_price":190.41,"expiration_date":"2026-08-07","underlying":"Common Stock","underlying_shares":9968},"source":{"system":"sec-edgar","filing":"0000914190-19-000259","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419019000259/edgar.xml","form_type":"4"}},{"id":3442838,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Restricted Stock Units","published_at":"2019-08-09T20:11:23.000Z","date":"2019-08-07","kind":"grant","acquired":true,"shares":1969,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)."}],"balance_after":1969,"derivative":{"underlying":"Common Stock","underlying_shares":1969},"source":{"system":"sec-edgar","filing":"0000914190-19-000259","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419019000259/edgar.xml","form_type":"4"}},{"id":3509452,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Stock Options (Right to buy)","published_at":"2019-05-29T20:29:16.000Z","date":"2019-05-24","kind":"exercise","acquired":true,"shares":5400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully exercisable"}],"balance_after":5400,"derivative":{"exercise_price":94.35,"expiration_date":"2021-08-12","underlying":"Common Stock","underlying_shares":5400},"source":{"system":"sec-edgar","filing":"0001562180-19-003162","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218019003162/primarydocument.xml","form_type":"4"}},{"id":3509451,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2019-05-29T20:29:16.000Z","date":"2019-05-24","kind":"sale","acquired":false,"shares":5400,"price":200,"value":1080000.0,"ownership":{"direct":true},"balance_after":2189,"source":{"system":"sec-edgar","filing":"0001562180-19-003162","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218019003162/primarydocument.xml","form_type":"4"}},{"id":3509450,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2019-05-29T20:29:16.000Z","date":"2019-05-24","kind":"exercise","acquired":true,"shares":5400,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7589,"source":{"system":"sec-edgar","filing":"0001562180-19-003162","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218019003162/primarydocument.xml","form_type":"4"}},{"id":3849001,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Stock Options (Right to buy)","published_at":"2018-08-09T22:26:13.000Z","date":"2018-08-08","kind":"grant","acquired":true,"shares":7339,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vests in full or in part on 8/8/2021 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)."}],"balance_after":7339,"derivative":{"exercise_price":177.32,"expiration_date":"2025-08-08","underlying":"Common Stock","underlying_shares":7339},"source":{"system":"sec-edgar","filing":"0001562180-18-003543","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218018003543/primarydocument.xml","form_type":"4"}},{"id":3849000,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Stock Options (Right to buy)","published_at":"2018-08-09T22:26:13.000Z","date":"2018-08-08","kind":"grant","acquired":true,"shares":9786,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Vests 2,447 shares each on 8/8/2019, 8/8/2020,  and 2,446 shares each on  8/8/2021, 8/8/2022"}],"balance_after":9786,"derivative":{"exercise_price":177.32,"expiration_date":"2025-08-08","underlying":"Common Stock","underlying_shares":9786},"source":{"system":"sec-edgar","filing":"0001562180-18-003543","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218018003543/primarydocument.xml","form_type":"4"}},{"id":3848999,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Restricted Stock Units","published_at":"2018-08-09T22:26:13.000Z","date":"2018-08-08","kind":"grant","acquired":true,"shares":1374,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vests in full or in part on 8/8/2021 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Vests in full or in part on 8/8/2021 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)."}],"balance_after":1374,"derivative":{"underlying":"Common Stock","underlying_shares":1374},"source":{"system":"sec-edgar","filing":"0001562180-18-003543","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218018003543/primarydocument.xml","form_type":"4"}},{"id":3848998,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Stock Options (Right to buy)","published_at":"2018-08-09T22:26:13.000Z","date":"2018-08-07","kind":"disposition_to_issuer","acquired":false,"shares":1505,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On 8/7/2018, the Board of Directors authorized discretionary vesting for 5,995 performance options.  The remainder of the performance options were forfeited."}],"balance_after":5995,"derivative":{"exercise_price":108.49,"expiration_date":"2022-08-07","underlying":"Common Stock","underlying_shares":1505},"source":{"system":"sec-edgar","filing":"0001562180-18-003543","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218018003543/primarydocument.xml","form_type":"4"}},{"id":3848997,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Restricted Stock Units","published_at":"2018-08-09T22:26:13.000Z","date":"2018-08-07","kind":"disposition_to_issuer","acquired":false,"shares":241,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On 8/7/2018, the Board of Directors authorized discretionary vesting for 959 performance RSUs.  The remainder of the performance RSUs were forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On 8/7/2018, the Board of Directors authorized discretionary vesting for 959 performance RSUs.  The remainder of the performance RSUs were forfeited."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":241},"source":{"system":"sec-edgar","filing":"0001562180-18-003543","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218018003543/primarydocument.xml","form_type":"4"}},{"id":3848996,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Restricted Stock Units","published_at":"2018-08-09T22:26:13.000Z","date":"2018-08-07","kind":"exercise","acquired":false,"shares":959,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On 8/7/2018, the Board of Directors authorized discretionary vesting for 959 performance RSUs.  The remainder of the performance RSUs were forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On 8/7/2018, the Board of Directors authorized discretionary vesting for 959 performance RSUs.  The remainder of the performance RSUs were forfeited."}],"balance_after":241,"derivative":{"underlying":"Common Stock","underlying_shares":959},"source":{"system":"sec-edgar","filing":"0001562180-18-003543","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218018003543/primarydocument.xml","form_type":"4"}},{"id":3848995,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2018-08-09T22:26:13.000Z","date":"2018-08-07","kind":"tax_withholding","acquired":false,"shares":438,"price":180.14,"value":78901.32,"ownership":{"direct":true},"balance_after":2189,"source":{"system":"sec-edgar","filing":"0001562180-18-003543","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218018003543/primarydocument.xml","form_type":"4"}},{"id":3848994,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Common Stock","published_at":"2018-08-09T22:26:13.000Z","date":"2018-08-07","kind":"exercise","acquired":true,"shares":959,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2627,"source":{"system":"sec-edgar","filing":"0001562180-18-003543","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218018003543/primarydocument.xml","form_type":"4"}},{"id":4178924,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":121755,"kind":"person","name":"Furlow Brenda S.","position":1,"cik":"0001443851","reported_name":"Furlow Brenda S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP - General Counsel"}}],"security":"Stock Options (Right to buy)","published_at":"2017-10-30T20:57:52.000Z","date":"2017-10-26","kind":"grant","acquired":true,"shares":12670,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vest 3,167 shares each on 8/9/2018, 8/9/2019 and 3,168 shares each on 8/9/2020, 8/9/2021."}],"balance_after":12670,"derivative":{"exercise_price":125.05,"expiration_date":"2024-08-09","underlying":"Common Stock","underlying_shares":12670},"source":{"system":"sec-edgar","filing":"0001562180-17-003382","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218017003382/primarydocument.xml","form_type":"4"}}],"next_cursor":"2017-10-30T20:57:52.000000Z,4178924"}